Second transurethral resection and prognosis of high-grade non-muscle invasive bladder cancer in patients not receiving Bacillus Calmette-Guérin

Loading...
Thumbnail Image
Identifiers

Publication date

Authors

Palou-Redorta, J.
Fata Chillón, Fernando Ramón de
Rodríguez, O.

Advisors

Editors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics

Google Scholar

Research Projects

Organizational Units

Journal Issue

Abstract

The objective of this study is to define the natural history of T1G3 bladder tumor not receiving intravesical Bacillus Calmette-Guerin (BCG) and to assess the diagnostic and therapeutic value of a second transurethral resection (Re-TUR) in these patients. Retrospective study on the natural history of 210 patients treated at two institutions for T1G3 bladder carcinoma without associated CIS. In no case was BCG administered; 79 (37.6%) received TUR alone, and 131 (62.4%) Re-TUR 4–6 weeks later; 23 (12.4%) underwent cystectomy for tumor progression.

Description

UNESCO Subjects

Keywords

Bibliographic reference

Angulo, J. C., Palou, J., García-Tello, A., de Fata, F. R., Rodríguez, O., & Villavicencio, H. (2014). Second transurethral resection and prognosis of high-grade non-muscle invasive bladder cancer in patients not receiving Bacillus Calmette-Guérin. Actas Urológicas Españolas (English Edition), 38(3), 164-171.

Type of document